As of 2024-12-13, the Fair Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -152.14 | -225.33 | -351.51 | -432.84 | -336.56 | |
| YoY growth | -% | -48.11% | -56.00% | -23.14% | -42.41% | |
| Market Cap (mil) | 8,191.26 |
| P/E | |
| Forward P/E |
| EPS | -2.53 |
| Avg earnings growth rate | -42.41% |
| TTM earnings | -460.47 |